These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 37810433)

  • 1. Case report: The lesson from opioid withdrawal symptoms mimicking paraganglioma recurrence during opioid deprescribing in cancer pain.
    Ruggiero E; Pambuku A; Caccese M; Lombardi G; Gallio I; Brunello A; Ceccato F; Formaglio F
    Front Pain Res (Lausanne); 2023; 4():1256809. PubMed ID: 37810433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of non-opioid interventions to reduce opioid withdrawal symptoms in patients with chronic pain: a systematic review.
    Langejan AI; de Kleijn L; Rijkels-Otters HJBM; Chudy SFJ; Chiarotto A; Koes BW
    Fam Pract; 2022 Mar; 39(2):295-300. PubMed ID: 34849764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid Tapering in Fibromyalgia Patients: Experience from an Interdisciplinary Pain Rehabilitation Program.
    Cunningham JL; Evans MM; King SM; Gehin JM; Loukianova LL
    Pain Med; 2016 Sep; 17(9):1676-85. PubMed ID: 26755658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.
    Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
    Pain Physician; 2012 Jul; 15(3 Suppl):S67-116. PubMed ID: 22786449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful buprenorphine transition while overlapping with a full opioid agonist to treat chronic pain: a case report.
    Patel KV; Sahni S; Taylor LF
    J Osteopath Med; 2023 Jan; 123(1):1-5. PubMed ID: 36282967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid deprescribing: Qualitative perspectives from those with chronic non-cancer pain.
    Hamilton M; Gnjidic D; Christine Lin CW; Jansen J; Weir KR; Shaheed CA; Blyth F; Mathieson S
    Res Social Adm Pharm; 2022 Dec; 18(12):4083-4091. PubMed ID: 35963766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of CYP2D6 genotype on opioid use disorder deprescription: an observational prospective study in chronic pain with sex-differences.
    Muriel J; Barrachina J; Del Barco G; Carvajal C; Escorial M; Margarit C; Ballester P; Peiró AM
    Front Pharmacol; 2023; 14():1200430. PubMed ID: 37324467
    [No Abstract]   [Full Text] [Related]  

  • 8. Managing Cancer Pain, Monitoring for Cancer Recurrence, and Mitigating Risk of Opioid Use Disorders: A Team-Based, Interdisciplinary Approach to Cancer Survivorship.
    Goodlev ER; Discala S; Darnall BD; Hanson M; Petok A; Silverman M
    J Palliat Med; 2019 Nov; 22(11):1308-1317. PubMed ID: 31329500
    [No Abstract]   [Full Text] [Related]  

  • 9. Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
    Manchikanti L; Kaye AM; Knezevic NN; McAnally H; Slavin K; Trescot AM; Blank S; Pampati V; Abdi S; Grider JS; Kaye AD; Manchikanti KN; Cordner H; Gharibo CG; Harned ME; Albers SL; Atluri S; Aydin SM; Bakshi S; Barkin RL; Benyamin RM; Boswell MV; Buenaventura RM; Calodney AK; Cedeno DL; Datta S; Deer TR; Fellows B; Galan V; Grami V; Hansen H; Helm Ii S; Justiz R; Koyyalagunta D; Malla Y; Navani A; Nouri KH; Pasupuleti R; Sehgal N; Silverman SM; Simopoulos TT; Singh V; Solanki DR; Staats PS; Vallejo R; Wargo BW; Watanabe A; Hirsch JA
    Pain Physician; 2017 Feb; 20(2S):S3-S92. PubMed ID: 28226332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperbaric Oxygen Therapy for Pain, Opioid Withdrawal, and Related Symptoms: A Pilot Randomized Controlled Trial.
    Wilson M; Bindler RJ; Stanek K; Layton ME; Quock RM
    Pain Manag Nurs; 2022 Oct; 23(5):616-624. PubMed ID: 35393218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid deprescribing in patients with chronic noncancer pain: a systematic review of international guidelines.
    Hamilton M; Kwok WS; Hsu A; Mathieson S; Gnjidic D; Deyo R; Ballantyne J; Von Korff M; Blyth F; Lin CC
    Pain; 2023 Mar; 164(3):485-493. PubMed ID: 36001299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Australian guidelines for the treatment of alcohol problems: an overview of recommendations.
    Haber PS; Riordan BC; Winter DT; Barrett L; Saunders J; Hides L; Gullo M; Manning V; Day CA; Bonomo Y; Burns L; Assan R; Curry K; Mooney-Somers J; Demirkol A; Monds L; McDonough M; Baillie AJ; Clark P; Ritter A; Quinn C; Cunningham J; Lintzeris N; Rombouts S; Savic M; Norman A; Reid S; Hutchinson D; Zheng C; Iese Y; Black N; Draper B; Ridley N; Gowing L; Stapinski L; Taye B; Lancaster K; Stjepanović D; Kay-Lambkin F; Jamshidi N; Lubman D; Pastor A; White N; Wilson S; Jaworski AL; Memedovic S; Logge W; Mills K; Seear K; Freeburn B; Lea T; Withall A; Marel C; Boffa J; Roxburgh A; Purcell-Khodr G; Doyle M; Conigrave K; Teesson M; Butler K; Connor J; Morley KC
    Med J Aust; 2021 Oct; 215 Suppl 7():S3-S32. PubMed ID: 34601742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Good clinical practice guide for opioids in pain management: the three Ts - titration (trial), tweaking (tailoring), transition (tapering).
    Coluzzi F; Taylor R; Pergolizzi JV; Mattia C; Raffa RB
    Braz J Anesthesiol; 2016; 66(3):310-7. PubMed ID: 27108830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid tapering in hematopoietic progenitor cell transplant recipients.
    Pederson C; Parran L
    Oncol Nurs Forum; 2000 Oct; 27(9):1371-80. PubMed ID: 11058969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensity of Withdrawal Symptoms During Opioid Taper in Patients with Chronic Pain-Individualized or Fixed Starting Dosage?
    Bienek N; Maier C; Kaisler M; Michel-Lauter B; Schwarzer A; Meyer-Frießem CH
    Pain Med; 2019 Dec; 20(12):2438-2449. PubMed ID: 30806672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Provider knowledge, beliefs, and self-efficacy to deprescribe opioids and sedative-hypnotics.
    Gray SL; Fornaro R; Turner J; Boudreau DM; Wellman R; Tannenbaum C; Marcum ZA; Balderson B; Cook A; Jacobsen AL; Phelan EA
    J Am Geriatr Soc; 2023 May; 71(5):1580-1586. PubMed ID: 36546768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient Engagement Survey Regarding Future Double-Blinded, Randomized Controlled Trial of Tapering of Chronic Opioid Therapy.
    James J; Lai B; Witt T
    J Prim Care Community Health; 2019; 10():2150132719890231. PubMed ID: 31777325
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.